VEGF-B
Showing 1 - 25 of >10,000
VEGF-B Signaling Pathway in Obesity and Metabolic Disease
Completed
- Obesity
- Metabolic Disease
-
Wuhan, Hubei, ChinaDepartment of Endocrinology, Union Hospital,Tongji Medical Colle
Apr 5, 2021
Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)
Not yet recruiting
- Ovarian Cancer
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2022
Tumors Malignant Trial in Shanghai (B1962)
Not yet recruiting
- Neoplasms Malignant
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Dec 13, 2022
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for
Recruiting
- Hepatocellular Carcinoma Non-resectable
- HAIC
- +8 more
-
Quanzhou, Fujian, China
- +1 more
Jan 26, 2023
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for
Recruiting
- Hepatocellular Carcinoma Non-resectable
- TACE
- +8 more
-
Quanzhou, Fujian, China
- +3 more
Jan 29, 2023
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Metastatic Cancer Trial in Amsterdam (hVEGF26-104/RFASE)
Completed
- Metastatic Cancer
- hVEGF26-104/RFASE
-
Amsterdam, North Holland, NetherlandsVU University Medical Center
Apr 14, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States
Active, not recruiting
- Brain Stem Glioma
- +4 more
- Bevacizumab
- +2 more
-
Birmingham, Alabama
- +136 more
Oct 15, 2022
Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)
Not yet recruiting
- Hepatocellular Carcinoma by BCLC Stage
- Bevacizumab Biosimilar QL 1101
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 20, 2023
Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)
Terminated
- Uveitis
- +3 more
- intravitreal injection of Conbercept
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (PUMCH)
Oct 24, 2022
Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)
Completed
- Angiogenesis
- Endometriosis
- Leuprolide Acetate
-
Patra, Peloponnese, Greece
- +1 more
Oct 27, 2023
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Retinopathy of Prematurity Trial in Cairo (Intravitreal Bevacizumab)
Completed
- Retinopathy of Prematurity
- Intravitreal Bevacizumab
-
Cairo, EgyptFaculty of Medicine Cairo University
Feb 1, 2023
Carcinoma, Hepatocellular Trial in Japan (Avelumab (MSB0010718C), Axitinib (AG-013736))
Completed
- Carcinoma, Hepatocellular
- Avelumab (MSB0010718C)
- Axitinib (AG-013736)
-
Nagoya, Aichi, Japan
- +6 more
Sep 1, 2020
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Phoenix, Arizona
- +91 more
Apr 22, 2021
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022
Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2
Recruiting
- Eye Diseases
- +2 more
- Pars plana vitrectomy
- +3 more
-
Chelmsford, Essex, United Kingdom
- +13 more
Aug 2, 2022
Diabetic Retinopathy and Diabetic Macular Edema
Not yet recruiting
- Diabetic Retinopathy
- +2 more
- (no location specified)
Apr 11, 2022
COVID-19 Pneumonia Trial in Jinan (Bevacizumab)
Recruiting
- COVID-19 Pneumonia
- Bevacizumab
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 13, 2023